Health and Medical News FRIDAY, May 2, 2014 (HealthDay News) -- A panel of expert advisors to the U.S. Food and Drug Administration on Friday voted overwhelmingly against moving the allergy drug Singulair from prescription to over-the-counter status. The panel voted 11-t...
by via @ Health and Medical News
by via @ Health and Medical News